Patient Guide: A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV

Why Use Quri.ai for This Trial?

  • ✓ Simplified eligibility checker - know if you qualify in minutes
  • ✓ Direct contact with study coordinators at 9 locations
  • ✓ Plain language explanations of medical terms and procedures
  • ✓ Personalized enrollment support throughout your journey
  • ✓ Free service - no hidden fees or obligations
Trial ID: NCTNCT07053384
Status: 🟢 Enrolling Now
Condition: HIV Infections
Phase: PHASE1

Where You Can Participate

This study is available at 9 locations across the country.

Top locations include:
  • • Bakersfield, California
  • • San Diego, California
  • • Ft. Pierce, Florida
  • • And 6 more locations

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study to Investigate the Use of VH3810109 With or Without Fostemsavir (FTR) to Reduce the Size and Activity of the Viral Reservoir in People Living With HIV - Join Clinical Trial NCTNCT07053384

How to Join This Clinical Trial - NCTNCT07053384

Learn how to participate in this PHASE1 trial studying an investigational therapy for HIV Infections. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with HIV Infections. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
HIV Infections
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07053384 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 9 locations. Find a study site near you:

Clinical Research Site

Bakersfield, California 93301 - United States

Status: RECRUITING

Clinical Research Site

San Diego, California 92103 - United States

Status: RECRUITING

Clinical Research Site

Ft. Pierce, Florida 34982 - United States

Status: RECRUITING

Clinical Research Site

Orlando, Florida 32803 - United States

Status: RECRUITING

Clinical Research Site

Kansas City, Missouri 64111 - United States

Status: RECRUITING

Clinical Research Site

St Louis, Missouri 63110 - United States

Status: RECRUITING

Clinical Research Site

Cincinnati, Ohio 45267 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75208 - United States

Status: RECRUITING

Clinical Research Site

Dallas, Texas 75246 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for HIV Infections:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai Study Finder

Quri.ai's Study Finder is the leading clinical trial business intelligence platform, helping BD professionals:

  • Discover clinical trials before competitors
  • Access exclusive contact information
  • Track sponsor pipelines and opportunities
  • Connect with decision makers directly
  • Win more business partnerships